Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cellsJun Shimizu, Tatsuo Shioda, Tadahiro Sasaki et al.|Scientific Reports|2022Cited by 48
The potential of COVID-19 patients’ sera to cause antibody-dependent enhancement of infection and IL-6 productionJun Shimizu, Tatsuo Shioda, Pedro E. Cruz et al.|Scientific Reports|2021Cited by 25
Genetic regions affecting the replication and pathogenicity of dengue virus type 2Yoshihiro Samune, Tatsuo Shioda, Akatsuki Saito et al.|PLoS neglected tropical diseases|2024Cited by 10
IFN-γ derived from activated human CD4+ T cells inhibits the replication of SARS-CoV-2 depending on cell-type and viral strainJun Shimizu, Tatsuo Shioda, Tadahiro Sasaki et al.|Scientific Reports|2024Cited by 6
Dengue virus type 3 infection in a traveler returning from Costa Rica to Japan in 2023Tadahiro Sasaki, Michinori Shirano, Ryo Morita et al.|Tropical Medicine and Health|2024Cited by 1